BACKGROUND Driving is a complex form of activity involving especially cognitive and psychomotor functions. These functions may be impaired by Parkinson’s disease. The relation between Parkinson’s disease and driving ability is still obscure and clinicians have to make decisions concerning the driving ability of their patients based on insufficent information. Until now no studies have compared different methods for evaluating the driving ability of patients with Parkinson’s disease.
METHODS The driving ability of 20 patients with idiopathic Parkinson’s disease and 20 age and sex matched healthy control subjects was evaluated by a neurologist, psychologist, vocational rehabilitation counsellor, and driving instructor using a standard 10 point scale. The patients and controls also evaluated their own driving ability. Cognitive and psychomotor laboratory tests and a structured on road driving test were used for evaluating the subjects’ driving ability.
RESULTS The patients with Parkinson’s disease performed worse than the controls both in the laboratory tests and in the driving test. There was a high correlation between the laboratory tests and driving test both in the patient group and in the control group. Disease indices were not associated with the driving test. The neurologist overestimated the ability of patients with Parkinson’s disease to drive compared with the driving ability evaluated by the structured on road driving test and with the driving related laboratory tests. Patients themselves were not capable of evaluating their own ability reliably.
CONCLUSION Driving ability is greatly decreased in patients with even mild to moderate Parkinson’s disease. The evaluation of patients’ driving ability is very difficult to carry out without psychological and psychomotor tests and/or a driving test.
- Parkinson’s disease
- driving ability
- psychomotor performance
- driving test
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Driving a car is a highly complicated form of activity carried out in a constantly changing environment. It consists of perception, information processing, and decision making and requires the drivers to carry out simultaneous tasks which in particular stress the visual and visuospatial cognitive and psychomotor functions, as well as attentive resources.1-4
Parkinson’s disease causes progressive motor dysfunction and possible impairment of cognitive and psychomotor functions.5 6 All these functions are essential to driving a car. The short term working memory and non-verbal recognitive memory are also impaired in Parkinson’s disease7-9; this may be connected to dopaminergic stimulation.10 Although the existence of generalised visuospatial deficits caused by Parkinson’s disease is disputed,11-13 there is considerable evidence suggesting that the disease impairs visuoperceptual functions.14Parkinsonian patients have problems in maintaining their attention,15 especially when a task is relatively complex.16 17 As regards the reaction times of patients with Parkinson’s disease there are contradictory results: some investigators have found significantly slower reaction times in patients with Parkinson’s disease than in healthy controls11 18 19 whereas others have found no differences,20 or if differences existed, they only appeared in complex situations.21 In addition the information processing abilities of patients with Parkinson’s disease are weak,22-25 and the more complex the task undertaken, the more frequent the difficulties manifested.26
Although it is well known that cognitive and psychomotor functions are impaired by Parkinson’s disease, there are, still, only a few studies on the relation between Parkinson’s disease and the ability to drive a car.6 27-29 McLay29studied the driving ability and the history of a small, heterogeneous Parkinson’s disease group and found that some of their driving accidents were probably caused by the disease. Dubinsky et al 27 reported that accidents are more common among patients with more severe Parkinson’s disease (Hoehn and Yahr III) than among patients with less severe disease (Hoehn and Yahr I) or healthy controls. However, their conclusion was that severity scales (The Northwestern University disability scale, the Schwab and England activities of daily living scale, and the Hoehn and Yahr scale) did not reliably predict inability to drive. Madeley et al 6 discovered in their laboratory study a correlation between the severity of Parkinson’s disease measured by Webster’s rating scale and simulated driving reaction time and accuracy. Lings et al 28 showed in their simulator study that inpatients with Parkinson’s disease, reactions are considerably slower, and they commit a greater number of errors than healthy people. However, to our knowledge there are no systematic studies considering the compatibility of different methods for estimating the ability of patients with Parkinson’s disease to drive.
To evaluate the driving ability of patients with Parkinson’s disease, we performed a study using clinical evaluation, cognitive and psychomotor laboratory tests, and a standardised on road driving test.
Subjects and methods
Twenty consecutive patients with idiopathic Parkinson’s disease (mean age 59 (SD 11) years) were recruited from the outpatient clinic of the Department of Neurology, University Hospital of Oulu, Finland. The criteria for inclusion were male sex, mild to moderate Parkinson’s disease (Hoehn and Yahr stages 1–3), general good health, and regular car driving. Patients with other diseases as well as patients using any drugs (except those for the treatment of Parkinson’s disease) known to affect driving ability were excluded. Similarly, patients with levodopa induced dyskinesiae and on-off phenomena were excluded. Twenty healthy age matched men (mean age 55 (SD 6) years) with similar driving habits served as controls. Tables 1 and 2 show the clinical and driving characteristics of the patients and controls. All the patients were being treated with selegiline (daily dose 10 mg) and levodopa (mean daily dose 450 (SD 188) mg). Additionally, five patients were taking bromocriptine, one pergolide, and one entacapone.
Apart from three traffic accidents that had occurred in the Parkinson’s disease group during the past two years compared with none in the control group, there were no differences in the driving histories of the members of the two study groups.
This study was approved by the ethics committee of the Merikoski Rehabilitation and Research Centre, Oulu, Finland. Patient evaluations and all the laboratory and driving tests were performed after obtaining informed consent.
Clinical evaluations of all the patients were carried out on an outpatient basis by the same neurologist (JT). The clinical evaluation comprised a neurological examination and the mini mental state examination (MMSE). To rule out any on-off effects, neuropsychological assessments and on road driving tests were performed when the drivers with Parkinson’s disease considered that they were at their optimal level of performance.
Driving ability was assessed on a 10 point scale where 10 indicates an excellent ability, and 4 and below indicate that the subject is unable to drive safely. The ability of patients with Parkinson’s disease to drive was estimated by a neurologist, by a psychologist using tests and an interview, by a driving instructor on the basis of a driving test, and by the patients themselves using the same 10 point scale. All the evaluations were done without any interaction between the specialists. The evaluations of the controls were carried out in the same way as the patients’ evaluations, except that the neurologist’s place was taken by a vocational rehabilitation counsellor.
Both the patients and controls underwent the computer aided laboratory tests30 designed by the Austrian Road Safety Board31 and partially validated against driving measures.32 This test package comprises the following sections:
Visual short term memory—The material consists of 24 geometric figures. The subject has to memorise three consecutively presented figures at a time. The total time used for the test and the correct responses are registered.
Perceptual flexibility and decision making—Two hundred visual exercises are presented to the examinee. Processing time is unrestricted. The total time used for the test and the number of correct responses is taken into account.
Vigilance—Continuous vigilance is studied in low stimulus monitoring situations. The total number of test stimuli are 1000, of which 100 are critical. The stimuli appear at irregular intervals without advance warning. The number of correct and incorrect responses, as well as the mean value of reaction times are calculated.
Complex choice reaction time—This is used to measure the time required for a person to react to complex visual signals. The correct reactions and total number of errors are measured, together with the reaction time, which is subdivided into cognitive and motor components.
Information processing capacity and reactive stress tolerance test 33 —This test is designed to assess a person’s reactive behaviour under changing conditions. Three test phases each consist of 180 signals with different signal presentation rates: (a) an “easy” phase—36 signals/min, (b) the “stress” phase—63 signals/min, and (c) the “recovery” phase—56 signals/min. Correct, correct and within the time, delayed, omitted, incorrect, and multiple responses are registered in all three phases.
The on road test was performed both in urban and rural surroundings on a standard and relatively difficult route. The time of the day and weather conditions did not vary noticeably. The time needed to cover the route was about 45 minutes. The route was designed to be sufficiently difficult. The evaluation was always performed by the same driving instructor in a manner similar to the obligatory Finnish driving test, using the official form. Two levels of errors were classified on the basis of their severity: (1) risky faults which could lead to danger, and (2) offences—that is, serious infringements of traffic regulations.
Comparisons of the study group with the control group were calculated by Mann-Whitney U test. Correlation analyses (Pearson’s product moment correlation and Spearman’s rank correlation coefficient) were used to measure the association between different variables. Stepwise regression analyses were used to determine which variables explain the variation in faults and offences in the driving test.
Annual driving mileage and total driving experience were not related to faults or offences in the driving test either in the patient group or in the control group.
The evaluation of driving ability in the Parkinson’s disease group was a considerably more complicated task than the evaluation of a healthy person’s ability to drive a car (table 3). The neurologist’s evaluation of the driving ablity of the patients with Parkinson’s disease was much more optimistic than the traffic instructor’s evaluation (t=6.14 p<0.001) or the one made by the psychologist (t=5.69 p<0.001). The evaluations of the psychologist and the driving instructor of the Parkinson’s disease group’s ability to drive correlated to a high degree (Spearman’s rank correlation coefficient r=0.745 p<0.001), but there was no significant correlation between the assessments made by the the neurologist and the instructor (r=0.176), nor between the neurologist’s and the psychologist’s evaluations (r=0.220). The patients’ own evaluations differed significantly from those of the instructor (t=5.42 p<0.001) and of the psychologist (t=4.85 p<0.001). There was no disagreement between the three evaluations of the controls’ general driving ability, and the controls were able to evaluate their driving ability adequately by themselves. According to every assessment all the controls were able to drive a car.
The patients with Parkinson’s disease did worse than the controls in all the laboratory tests, the differences being most pronounced in the visual memory test, in the choice reaction time test, and in the test for information processing capacity in a complex situation (table 4). Both cognitive and psychomotor impairments were evident even in the mild to moderate stages of Parkinson’s disease.
The groups differed in the number of classified faults in the driving test. The patients committed significantly more risky faults and offences than the controls. The individual variation was more pronounced in the Parkinson’s disease group than in the control group (table 5). In terms of faults, driving in a traffic flow was a considerably more difficult task for the patients with Parkinson’s disease than for the controls (mean (SD) of Parkinson’s disease group 3.9 (SD 2.4), controls 1.6 (SD 1.4); p=0.018), as well as turning to the left (Parkinson’s disease group, mean 1.7 (SD 2.1), controls, mean 0.6 (SD 0.6); p=0.0461). The Parkinson’s disease group’s problems in driving appeared mostly in urban conditions, and the groups did not differ from each other in highway driving. The driving instructor’s overall evaluation correlated with the faults (Parkinson’s disease group r=−0.740 p<0.001; controlsr=−0.532 p<0.05) and the offences (Parkinson’s disease group r=−0.716 p<0.001; controlsr=−0.593 p<0.01) that occurred during the on road test, indicating that his evaluation was based on the recorded observation during the driving test.
The number of classified faults in the on road driving test correlated with laboratory tests (except for the visual memory test ) in both of the groups (table 6), supporting previous findings31-33that this test package measures the essential cognitive and psychomotor functions needed for driving a car.
Disease indices (such as duration of the disease, the Hoehn and Yahr scale, and the MMSE scale) did not show significant correlations with the results of the driving test. The dose of levodopa was slightly, but not significantly, associated with the driving test, and there was a slight positive correlation (r=0.479 p<0.05) between age and the faults in the driving test and between age and offences (r=0.504 p<0.05).
According to the stepwise regression model, slowness of visual processing, a dose of levodopa and age explained 67% of the variation in the faults in the driving test (total number of faults and offences) of the Parkinson’s disease group. If age was excluded, then the model explained 56% of the variation. When only the laboratory variables were included, slowness of visual processing, errors in perception, and slowness in recalling visual material explained 62% of the variation in faults. Correspondingly, the wrong decisions in the choice reaction time test and slowness in information processing explained 46% of the variation in faults in the driving test in the control group.
Our results show that Parkinson’s disease significantly influences driving ability even in the mild and moderate stages although most patients in this sample seemed sufficiently competent to drive. Secondly, the evaluation of the driving ability of patients with Parkinson’s disease seems to be a highly complicated task which even an experienced clinician cannot accomplish without the support of other specialists and driving related tests. The neurologist who took part in this study overestimated the driving ability his patients with Parkinson’s disease, despite his extensive contact with them, and the patients themselves were not at all capable of evaluating their own driving ability reliably. Seven patients out of 20 (35%), whom the neurologist approved to drive were evaluated as being unable to drive on the basis of the driving test; they still drove actively. Two of them, both ranked very low by the driving instructor (2 and 3 on the 10 point scale) and by the psychologist (3 and 5), had each caused a traffic accident in the past two years. A third patient who had also caused an accident was ranked fairly high by all three specialists (7, 8, and 7). The controls had not caused any accidents during the previous two years.
It should be noted that the range of evaluations differed substantially between the specialists. The driving instructor gave low scores, indicating disability, for seven patients with Parkinson’s disease and his range for the controls extended from five to nine. The psychologist also used almost the whole range, but the neurologist was fairly conservative, avoiding extreme values. Our results might simply arise from this scaling difference as the two specialists, aware of the fact that half of the subjects had Parkinson’s disease, may have indicated lower values whenever they noted any symptom of the disease. However, this is not a plausible explanation as there was no correlation between the evaluations of the neurologist and those of the driving instructor and the psychologist, and as the estimations of the last two (mutually independent) were based on structured observations in real traffic or on objective cognitive and psychomotor tests.
Who is right, then, in evaluations of driving ability? Our joint opinion is that we should place more trust on the driving instructor’s and the psychologist’s results, as their estimates are directly based on traffic specific information. In this study all the specialists were highly experienced, each of them having had at least five years of active work in this area, but only one specialist was used in each category. Therefore, to confirm the results larger patients groups, more evaluators in each category, and new evaluators (for example, general practitioners) should be included in further research.
A further point should be raised. The major problems experienced by the patients with Parkinson’s disease in the on road test occurred in fairly heavy traffic in an unfamiliar city. Drivers generally adapt their behaviour to the requirements set by traffic conditions, but they also tend to compensate for their impaired skills by avoiding difficult environments or situations.4 It is possible, therefore, that we put our subjects into too demanding conditions considering their driving needs. On the other hand, sufficient demands are necessary to create critical situations and variety which make a proper assessment of driving ability possible. However, the patients with Parkinson’s disease who were ranked by the driving instructor as being unable to drive evaluated their own skills as satisfactory or even good. Although they might have been pretending just to keep their driving licence, the lack of correlation between their self evaluation and the driving instructor’s evaluation suggests that their continued driving is likely to result in risks to themselves and to other road users.
Our results show that the cognitive and psychomotor impairment noticeable even in the early stages of Parkinson’s disease can be assessed through specific laboratory tests and on road tests. The results support the findings of Dubinsky et al 27 concerning the unreliability of questionnaires and severity scales in evaluations of driving ability. Similarly, we found no significant correlations between Hoehn and Yahr, MMSE, and the driving test. Disease indices such as duration of the disease and the dose of levodopa medication were not directly linked to performance in the driving test.
The laboratory tests used in the present study correlated to a high degree with the driving test both in the patient group and in the control group. The tests also distinguished patients with Parkinson’s disease from controls. Slowness of cognitive processing in Parkinson’s disease was the key factor in the test variables.13 24 26 According to our study an evaluation of the driving ability of patients with Parkinson’s disease should be based on a test package which includes at least the following tests: (1) vigilance and concentration, (2) visual perception, (3) choice reaction times, (4) information processing in a complex situation.
In conclusion, the driving ability of patients with even mild to moderate Parkinson’s disease is clearly impaired. The highly complex task of evaluating the driving ability of patients with Parkinson’s disease requires both psychological and psychomotor tests, and/or an on road driving test.